CytomX Therapeutics Inc (CTMX)vsInsmed Inc (INSM)
CTMX
CytomX Therapeutics Inc
$4.24
-4.93%
HEALTHCARE · Cap: $757.33M
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 696% more annual revenue ($606.42M vs $76.20M). INSM leads profitability with a -2.1% profit margin vs -22.8%. INSM earns a higher WallStSmart Score of 39/100 (F).
CTMX
Avoid26
out of 100
Grade: F
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 60.6% YoY
No standout strengths identified
Areas to Watch
Smaller company, higher risk/reward
ROE of -35.2% — below average capital efficiency
Revenue declined 98.3%
Negative free cash flow — burning cash
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : CTMX
The strongest argument for CTMX centers on EPS Growth.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : CTMX
The primary concerns for CTMX are Market Cap, Return on Equity, Revenue Growth.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
CTMX carries more volatility with a beta of 2.48 — expect wider price swings.
INSM is growing revenue faster at 1.5% — sustainability is the question.
CTMX generates stronger free cash flow (-23M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
INSM scores higher overall (39/100 vs 26/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CytomX Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company in the United States. The company is headquartered in South San Francisco, California.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?